Improving rates of pneumococcal vaccination on discharge from a tertiary center medical teaching unit: A prospective intervention

Thomas, Chandra M.; Loewen, Andrea; Coffin, Carla; Campbell, Norman R. C.
January 2005
BMC Public Health;2005, Vol. 5 Issue 1, p110
Academic Journal
Background: Pneumococcal disease causes significant morbidity and mortality in at-risk individuals, and is complicated by emerging antibiotic resistance. An effective, safe and cost-effective vaccine is available, but despite this many patients who would benefit from pneumococcal vaccination remain unvaccinated. The purpose of this study was to determine the rates of missed opportunities to provide pneumococcal vaccination to patients being discharged from a tertiary center medical teaching unit and to determine if a nurse coordinator-based intervention would increase rates of pneumococcal vaccination prior to discharge home. Methods: We conducted a prospective, controlled study in the setting of a Medical Teaching Unit at a tertiary care centre to assess the impact of a nurse coordinator based intervention on the rates of vaccination of eligible patients on discharge home. The rates of vaccination during an eight-week usual-care period (February 20 to April 16, 2002) and an eight-week intervention period (April 22 to June 16, 2002) were compared. Results: Prior to the intervention none of thirty-eight eligible patients were vaccinated prior to discharge home from the Medical Teaching Unit. After the intervention 27 (54%) of fifty eligible patients were vaccinated prior to discharge. Conclusion: There are significant missed opportunities to provide pneumococcal vaccination to inpatients who are discharged home from a medical unit. Using a patient care coordinator we were able to significantly improve the rates of vaccination on discharge.


Related Articles

  • Indirect Effect of 7-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Colonization among Unvaccinated Household Members. Millar, Eugene V.; Watt, James P.; Bronsdon, Melinda A.; Dallas, Jean; Reid, Raymond; Santosham, Mathuram; O'Brien, Katherine L. // Clinical Infectious Diseases;10/15/2008, Vol. 47 Issue 8, p989 

    Background. Since the introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in the United States, rates of invasive pneumococcal disease have decreased in both vaccinated and unvaccinated age groups. Reduction of invasive pneumococcal disease in unvaccinated groups has been attributed...

  • The Challenge of Reducing Invasive Pneumococcal Disease in Indigenous Indian Populations. Vanderkooi, Otto G.; Kellner, James D. // Clinical Infectious Diseases;5/1/2010, Vol. 50 Issue 9, p1247 

    In this article, the author discusses the efficacy of 7-valent pneumococcal conjugate vaccine (PCV7) in treating indigenous children suffering from invasive pneumococcal infections in the U.S. and Australia. The author notes the effectiveness of the said treatment to the non-indigenous people...

  • Infants too young to receive pneumococcal conjugate vaccine benefit from herd immunity. Carter, R. J. F. // Thorax;Jul2006, Vol. 61 Issue 7, p610 

    The article reports that infants too young to receive a heptavalent pneumococcal conjugate vaccine (PCV7) are benefiting from herd immunity. Evidence has shown that the rate of invasive pneumococcal disease (IPD) among children younger than 2 years has reduced since the introduction of PCV7....

  • Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998-2004. Hicks, Lauri A.; Harrison, Lee H.; Flannery, Brendan; Hadler, James L.; Schaffner, William; Craig, Allen S.; Jackson, Delois; Thomas, Ann; Beall, Bernard; Lynfield, Ruth; Reingold, Arthur; Farley, Monica M.; Whitney, Cynthia G. // Journal of Infectious Diseases;11/1/2007, Vol. 196 Issue 9, p1346 

    Background. Widespread use of pneumococcal conjugate vaccine (PCV7) resulted in decreases in invasive disease among children and elderly persons. The benefits may be offset by increases in disease due to serotypes not included in the vaccine (hereafter, ‘nonvaccine serotypes’). We...

  • Hospital-Based Pneumococcal Immunization. Fedson, David S.; Harward, Mary P.; Reid, Robert A.; Kaiser, Donald L. // JAMA: Journal of the American Medical Association;9/5/90, Vol. 264 Issue 9, p1117 

    Deals with a study which explored the potential usefulness of a strategy of hospital-based pneumococcal immunization in the U.S. Analysis of a population-based linked record of hospital discharges for Medicare enrollees in Shenandoah, Virginia; Percentage of the probability of readmission of...

  • Understanding S. Pneumoniae. Corry, Margarita; Whelan, Jacqueline // World of Irish Nursing & Midwifery;Sep2006, Vol. 14 Issue 8, p55 

    The article discusses the nature of streptococcus pneumonia also known as the pneumococcal pneumonia, a potentially vaccine-preventable disease which is among the leading causes of illness and death in young children worldwide. The disease is caused by an anaerobic gram positive bacterium. It is...

  • A Randomized, Double-Blind Trial of Pneumococcal Vaccination in Adult Allogeneic Stem Cell Transplant Donors and Recipients. Kumar, Deepali; Maggie Hong Chen; Welsh, Brenda; Siegal, Deborah; Cobos, Isabel; Messner, Hans A.; Lipton, Jeff; Humar, Atul // Clinical Infectious Diseases;12/15/2007, Vol. 45 Issue 12, p1576 

    Background. Adult allogeneic hematopoietic stem cell transplant (HSCT) recipients are at high risk of invasive pneumococcal disease but have suboptimal responses to the recommended pneumococcal polysaccharide vaccine (PPV23). Pneumococcal conjugate vaccine (PCV7) may improve immunogenicity in...

  • Population-Based Results for Pneumococcal Conjugate Vaccine. Zepf, Bill // American Family Physician;1/1/2004, Vol. 69 Issue 1, p193 

    Presents a study which examined the impact of the introduction of protein-polysaccharide conjugate vaccine in reducing the incidence of invasive pneumococcal disease in young children. Analysis of data; Baseline rate of invasive pneumococcal disease among children younger than two years;...

  • Changing Characteristics of Invasive Pneumococcal Disease in Metropolitan Atlanta, Georgia, after Introduction of a 7-Valent Pneumococcal Conjugate Vaccine. Albrich, W. C.; Baughman, W.; Schmotzer, B.; Farley, M. M. // Clinical Infectious Diseases;6/15/2007, Vol. 44 Issue 12, p1569 

    Background. The rate of invasive pneumococcal disease (IPD) has decreased among both immunized children and nonimmunized adults since the licensure of a heptavalent pneumococcal conjugate vaccine (PCV7) for use in infants in the United States in 2000. Methods. Temporal trends in IPD incidence,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics